FDA NDC Directory · JSON-LD · Markdown

Lenalidomide

NDC 0378-1935 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA213912
Dosage form / routeCAPSULE · ORAL
Active ingredientsLENALIDOMIDE (2.5 mg/1)
Marketing started20220906
Package count2

External sources

Source: openFDA. Public-domain (CC0).